Contact Us
For product information
P: 1-866-273-7846
E: OraPharma@OraPharma.com
For business and employment inquiries
E: info@OraPharma.com
For directions to our offices
Map: click here
For product information
P: 1-866-273-7846
E: OraPharma@OraPharma.com
For business and employment inquiries
E: info@OraPharma.com
For directions to our offices
Map: click here
We aspire to be a leader in oral health by developing products that make a meaningful difference in patients’ oral health.
Periodontitis, also known as gum disease, affects more than 50 million Americans and is the primary cause of tooth loss in adults.
ARESTIN® (minocycline hydrochloride) is indicated as an adjunct to scaling and root planing (SRP) procedures for reduction of pocket depth in patients with adult periodontitis. Clinical studies show that ARESTIN® with SRP is up to 3x more effective than SRP alone.
Using advanced microsphere technology, ARESTIN® releases its medicine over time to kill the bacteria that help cause periodontitis. Currently, ARESTIN® is the leading locally administered antibiotic for the treatment of periodontitis.
Clinical trial data demonstrate clear benefits from active treatment with ARESTIN® plus SRP:
Please see below for important safety information about ARESTIN®.
Our portfolio also includes a partnership with Johnson & Johnson Healthcare Products to offer our customers the LISTERINE® family of products, which includes LISTERINE® Antiseptic, LISTERINE® TotalCare™ Anti-cavity mouthwash, and LISTERINE® Zero™, as well as REACH® brushes and flosses—brands with a long-standing tradition of innovation. We also partner with DePuy Spine Inc. to offer HEALOS® Bone Graft Replacement. These partnerships complement our other oral care products.
LISTERINE® TotalCare™ Anti-cavity mouthwash, powered by Rapid Fusion technology™, is formulated to maximize fluoride uptake and remineralization of enamel for better cavity protection. LISTERINE® Antiseptic is the only OTC nationally branded antimicrobial mouthwash that has earned the ADA Seal of Acceptance for fighting plaque and gingivitis. Listerine® Zero™ is also now available for patients who prefer an alcohol-free rinse. REACH® brushes and flosses feature ergonomic designs and MICRO-GROOVES™ Technology, which can lead to better patient compliance.
HEALOS® Dental Bone Graft Substitute is intended to fill, augment, or reconstruct periodontal and/or bony defects of the upper or lower jaw. HEALOS® is a bone graft substitute that is resorbed and remodeled into new bone as part of the natural healing process.
For more information about HEALOS®, including full Prescribing Information, visit www.HEALOSfordental.com
ARESTIN® is indicated as an adjunct to scaling and root planing (SRP) procedures for reduction of pocket depth in patients with adult periodontitis. ARESTIN® may be used as part of a periodontal maintenance program, which includes good oral hygiene and SRP.
ARESTIN® should not be used in any patient who has a known sensitivity to minocycline or tetracyclines. The use of drugs of the tetracycline class during tooth development may cause permanent discoloration of the teeth, and therefore should not be used in children or in pregnant or nursing women. Hypersensitivity reactions that included, but were not limited to, anaphylaxis, angioneurotic edema, urticaria, rash, swelling of the face, and pruritus have been reported with the use of ARESTIN®. In clinical trials, the most frequently reported nondental treatment-emergent adverse events were headache, infection, flu syndrome, and pain.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088
For additional important safety information, including the ARESTIN® full Prescribing Information, visit www.MyARESTIN.com (for dental professionals) or www.ARESTIN.com (for patients).
OraPharma, Inc. is solely responsible for the content of this site, which is intended for US residents only.
© OraPharma, Inc. 2007-2012
